Held on 5–6 December 2025 in Dubai, the 14th Diabetes & Ramadan International Alliance Conference (DaR 2025) reaffirmed its position as the world’s leading scientific platform dedicated to optimizing diabetes management during Ramadan fasting. The conference brought together a truly global community of clinicians, researchers, and healthcare leaders committed to advancing evidence-based, patient-centered diabetes care for fasting populations.

With over 2,800 healthcare professionals from 21 countries, including 300+ in-person attendees and more than 2,200 virtual participants, DaR 2025 demonstrated the growing global demand for structured guidance on safe fasting, insulin adjustment, and digital diabetes solutions during Ramadan.

A Global Scientific Assembly Focused on Real-World Practice

DaR 2025 achieved a 70% overall attendance rate, reflecting strong engagement across both physical and virtual formats. Participants connected from regions spanning Europe, the Middle East, Africa, Asia, and North America, reinforcing the conference’s role as a truly international knowledge hub for endocrinology and metabolic health.

Accredited with 11.5 CME hours, the program delivered high-value clinical education designed to translate directly into practice, particularly in regions where Ramadan fasting and diabetes intersect at scale.

Key Scientific Milestone

The defining scientific highlight of DaR 2025 was the official launch of the 2025 DaR-ADA-IDF Ramadan Guidelines, marking a major advancement in global standards for diabetes care during fasting, Insulin pump management during Ramadan, including safety considerations, Digital health integration, including continuous glucose monitoring and decision-support tools, Pediatric diabetes care during Ramadan, an area often underrepresented in clinical guidance, and Complex case scenario workshops, offering practical, case-based learning grounded in real patient challenges

The launch of the DaR-ADA-IDF Ramdan Guidelines was the cornerstone of the conference. Early feedback indicates that these topics are already influencing clinical decision-making across multiple healthcare systems.

Expert-Led Sessions Driving Practical Change

Distinguished speakers including Dr. Mohamed Hassanein, Dr. Reem Alamoudi, and Dr. Binte Zainudin, alongside an international faculty of experts, delivered sessions that balanced scientific rigor with clinical applicability. Discussions consistently emphasized risk stratification, patient education, and individualized care pathways, reinforcing DaR’s commitment to improving outcomes rather than issuing generic recommendations.

Participant testimonials highlighted the practical value of the sessions, particularly the guideline presentations and case-based workshops, which many described as immediately applicable to daily practice.

Hybrid Engagement That Worked

DaR 2025 demonstrated that hybrid scientific meetings can be both scalable and meaningful when designed correctly. Virtual participants reported high engagement levels, seamless platform performance, and interactive participation despite geographical distance. This hybrid success expands DaR’s educational reach while preserving the depth of scientific exchange.

Professional Execution Powered by ICOM Gulf

The successful delivery of DaR 2025 was underpinned by the professional expertise of ICOM Gulf, whose end-to-end conference management ensured seamless operations across scientific programming, branding, production, and hybrid platform delivery. From maintaining the visual integrity of the DaR brand to orchestrating a complex multi-format experience, ICOM Gulf translated DaR’s scientific stature into a polished, globally resonant conference experience.

Looking Ahead to DaR 2026

As the newly launched guidelines move from discussion to implementation, DaR 2025 stands as a turning point in global Ramadan diabetes care. The DaR 2026 International Conference, scheduled for 6–7 November 2026, promises to build on this momentum, with location details to be announced soon.

Stay connected, revisit the highlights, and be part of the next chapter in advancing safe, evidence-based diabetes care during Ramadan.